| Author(s) | |
|---|---|
| Publication Year | |
| Publisher |
Key opinion leaders, clinical practice guidelines and medical societies
getting the message out
From: Doctors in Denial
$3.10
Examines the impact of the conflicts of interest that occur when Canadian researchers and Canadian medical societies rely on pharmaceutical companies for favours, trips, and research funding.
Contributors
Joel Lexchin MD
JOEL LEXCHIN, MD, is an internationally-recognized expert in pharmaceutical policy. He received his MD from the University of Toronto and has spent over thirty years working as an emergency physician in the Toronto area. He taught health policy and is a Professor Emeritus in the School of Health Policy and Management at York University. He has been an advocate for change in pharmaceutical policy for thirty-five years, has appeared before numerous parliamentary committees, and has authored or co-authored over 150 articles about all aspects of how medicines are developed and used.
